These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8225207)

  • 1. Simvastatin influences testicular steroidogenesis in human.
    Rossato M; Guarneri G; Lavagnini T; Padovan D; Foresta C
    Horm Metab Res; 1993 Sep; 25(9):503-5. PubMed ID: 8225207
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of long-term simvastatin treatment on testicular and adrenal steroidogenesis in hypercholesterolemic patients.
    Bernini GP; Argenio GF; Gasperi M; Vivaldi MS; Franchi F; Salvetti A
    J Endocrinol Invest; 1994 Apr; 17(4):227-33. PubMed ID: 7930373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use and effect of simvastin in patients with type II diabetes].
    Camarda G
    Clin Ter; 1993 Aug; 143(2):105-7. PubMed ID: 8222540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes mellitus, hypercholesterolemia, and therapeutic prospects with simvastatin. General considerations and personal contribution].
    Pipicelli G; Pentimone F; Frustaci G; Notarangelo R; Beghè F
    Minerva Med; 1992 Dec; 83(12):819-25. PubMed ID: 1491762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
    Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A
    Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.
    Castelao AM; Griñó JM; Andrés E; Gilvernet S; Serón D; Castiñeiras MJ; Roca M; Galcerán JM; González MT; Alsina J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1043-6. PubMed ID: 8442035
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of simvastatin on serum lipids and atherosclerosis in WHHL rabbits.
    Fukuo Y; Nagashima M; Saitoh A; Kobayashi Y; Terashi A; Nakama K; Kameyama K; Asano G
    Clin Ther; 1991; 13(3):417-24. PubMed ID: 1954642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
    Ide H; Fujiya S; Aanuma Y; Agishi Y
    Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
    Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF
    Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia.
    Purvis K; Tollefsrud A; Rui H; Haug E; Norseth J; Viksmoen L; Ose L; Lund H
    Eur J Clin Pharmacol; 1992; 42(1):61-4. PubMed ID: 1541317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus.
    Sartor G; Katzman P; Eizyk E; Kalén J; Nilsson A; Ugander L; Ursing D
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):3-6. PubMed ID: 7711988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of simvastatin on atherogenic blood lipid pattern].
    Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F
    Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
    Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of simvastatin on blood levels of lipoprotein (a)].
    Galetta F; Sampietro T; Basta G; Giannasi G; Bionda A
    Minerva Med; 1995; 86(7-8):299-303. PubMed ID: 7478073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simvastatin in the treatment of familial hypercholesterolemia].
    Ceska R; Sobra J; Procházková R; Kvasilová M
    Cas Lek Cesk; 1995 May; 134(10):310-3. PubMed ID: 7788650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
    Marnini P; Colombo F; Cattaneo R; Geroli L; Venco A
    Int J Clin Pharmacol Res; 1992; 12(2):65-70. PubMed ID: 1428300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.